Andlauer Healthcare Group Inc.
AND.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 474.74M | 478.79M | 478.64M | 477.79M | 480.10M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 474.74M | 478.79M | 478.64M | 477.79M | 480.10M |
| Cost of Revenue | 315.56M | 317.64M | 318.92M | 318.77M | 320.34M |
| Gross Profit | 159.18M | 161.15M | 159.72M | 159.02M | 159.76M |
| SG&A Expenses | 38.87M | 39.18M | 38.89M | 37.92M | 38.11M |
| Depreciation & Amortization | 51.79M | 51.93M | 52.06M | 51.71M | 50.50M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 406.23M | 408.76M | 409.87M | 408.41M | 408.95M |
| Operating Income | 68.52M | 70.03M | 68.77M | 69.39M | 71.14M |
| Income Before Tax | 64.33M | 66.04M | 65.32M | 65.68M | 67.12M |
| Income Tax Expenses | 17.31M | 17.89M | 17.68M | 17.84M | 18.12M |
| Earnings from Continuing Operations | 47.03 | 48.15 | 47.64 | 47.84 | 48.99 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 47.03M | 48.15M | 47.64M | 47.84M | 48.99M |
| EBIT | 68.52M | 70.03M | 68.77M | 69.39M | 71.14M |
| EBITDA | 109.13M | 94.51M | 93.75M | 102.71M | 112.45M |
| EPS Basic | 1.17 | 1.18 | 1.15 | 1.15 | 1.17 |
| Normalized Basic EPS | 1.00 | 1.01 | 0.99 | 0.99 | 1.01 |
| EPS Diluted | 1.15 | 1.16 | 1.13 | 1.13 | 1.16 |
| Normalized Diluted EPS | 0.99 | 0.99 | 0.97 | 0.97 | 0.99 |
| Average Basic Shares Outstanding | 161.13M | 163.13M | 165.62M | 166.43M | 166.96M |
| Average Diluted Shares Outstanding | 163.57M | 166.01M | 168.68M | 169.63M | 170.21M |
| Dividend Per Share | 0.31 | 0.29 | 0.28 | 0.27 | 0.25 |
| Payout Ratio | 25.95% | 24.64% | 24.14% | 23.22% | 21.48% |
